Description Module

Description Module

The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.

Description Module path is as follows:

Study -> Protocol Section -> Description Module

Description Module


Ignite Creation Date: 2025-12-24 @ 2:51 PM
Ignite Modification Date: 2025-12-24 @ 2:51 PM
NCT ID: NCT01801059
Brief Summary: This randomized clinical trial focused on activating the patient to ask their health care provider for a colorectal cancer screening test to improve screening rates for colorectal cancer. The patient activation intervention may increase information seeking, number of screening tests ordered and number of completed screening tests for colorectal cancer.
Detailed Description: PRIMARY OBJECTIVES: I. To test a patient activation intervention to improve colorectal cancer (CRC) screening rates using fecal occult blood test (FOBT) among male and female patients 50 years and older from the East Central Columbus Neighborhood Health Center. SECONDARY OBJECTIVES: I. To assess if there is a change in knowledge and attitudes about CRC screening after watching the educational video. II. To assess the effectiveness of providing communication skills training for improving discussion focusing on CRC screening during the patient-provider visit. OUTLINE: Patients are randomized to 1 of 2 arms prior to a medical visit. ARM I (Education only): Patients receive CRC and CRC screening information by an educational video and a brochure with healthy hints to prevent CRC. ARM II (Education and patient activation): Patients receive CRC and CRC screening information and communication skills training (patient activation) intervention by educational video and brochure and a brochure about healthy hints to prevent CRC. After the medical visit, patients' medical records are reviewed at 1 month and 2 months after the visit to document CRC screening completion.
Study: NCT01801059
Study Brief:
Protocol Section: NCT01801059